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Brief Definit ive Report
Clinical symptoms of malaria are associated 
with Plasmodium infection of RBCs. Human 
Plasmodium falciparum parasites catabolize more 
than half of the hemoglobin (Hb) in the RBCs 
(Goldberg, 2005). The amino acids derived from 
Hb proteolysis are used for protein synthesis 
and energy metabolism. The proteolysis of Hb 
is accompanied by the release of free heme, 
which is cytotoxic for the parasite and is rapidly 
detoxified and converted into hemozoin (Hz). 
Therefore, both Hb degradation and heme 
detoxification are considered to be essential for 
P. falciparum survival (Goldberg, 2005). The diges-
tion of Hb is a conserved and semiordered pro-
cess, which principally occurs within the acidified 
digestive vacuole (DV). After the initial cleavage 
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Most studies on malaria-parasite digestion of hemoglobin (Hb) have been performed using 
P. falciparum maintained in mature erythrocytes, in vitro. In this study, we examine Plas-
modium Hb degradation in vivo in mice, using the parasite P. berghei, and show that it is 
possible to create mutant parasites lacking enzymes involved in the initial steps of Hb 
proteolysis. These mutants only complete development in reticulocytes and mature into 
both schizonts and gametocytes. Hb degradation is severely impaired and large amounts  
of undigested Hb remains in the reticulocyte cytoplasm and in vesicles in the parasite. The 
mutants produce little or no hemozoin (Hz), the detoxification by-product of Hb degrada-
tion. Further, they are resistant to chloroquine, an antimalarial drug that interferes with  
Hz formation, but their sensitivity to artesunate, also thought to be dependent on Hb 
degradation, is retained. Survival in reticulocytes with reduced or absent Hb digestion may 
imply a novel mechanism of drug resistance. These findings have implications for drug 
development against human-malaria parasites, such as P. vivax and P. ovale, which develop 
inside reticulocytes.
© 2015 Lin et al. This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial– 
Share Alike 3.0 Unported license, as described at http://creativecommons.org/ 
licenses/by-nc-sa/3.0/).
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protein (HDP) and 3 enzymes related to DV proteases with 
undefined roles in Hb digestion (berghepain 1, the ortholog of 
P. falciparum falcipain 1 and 2 dipetidyl peptidases, DPAP2 and 
DPAP3). We successfully generated gene-deletion mutants for 
pm4, bp1, bp2, dpap1, dpap2, dpap3, app, lap, and dap; however, 
multiple attempts to disrupt bln, aap, and hdp were unsuccessful 
(Table S2). We previously reported that disruption of pm4 in 
P. berghei results in the lack of all aspartic protease activity in 
the DV (Spaccapelo et al., 2010). Similarly, P. falciparum has 
been shown to survive without DV PM activity (Bonilla et al., 
2007). We were able to generate mutants lacking BP2, whereas 
P. falciparum blood stages survive without FP2 but not FP3 
(Sijwali et al., 2006). We also generated mutants that lack 
genes encoding DPAP1, APP, and LAP, whereas P. falciparum 
orthologs have been reported to be refractory to disruption 
(Table S1; Klemba et al., 2004; Dalal and Klemba, 2007). We 
were unable to select parasites lacking expression of AAP and 
BLN, and the P. falciparum orthologous genes aap and bln have 
also been reported to be resistant to disruption and shown to 
play additional roles outside DV (Dalal and Klemba, 2007; 
Ponpuak et al., 2007). We were also unable to select mu-
tants lacking HDP expression, suggesting an essential role for 
P. berghei blood stages, as has been proposed for P. falciparum 
HDP (Jani et al., 2008). The successful deletion of 6 of the 
8 genes encoding hemoglobinase indicates a high level of re-
dundancy in vivo among these enzymes.
Mutants lacking PM4, DPAP1, BP1, LAP or APP exhib-
ited a significant reduction in asexual multiplication rates 
(growth rates) compared with WT parasites, whereas growth 
rates of the other 4 mutants were not significantly reduced 
(Table 1). In addition, pm4 and app mutants showed a signif-
icant reduction in Hz production quantified in mature schizonts 
(Sz; 8–24 nuclei) using reflection contrast polarized light mi-
croscopy (Fig. 1, A and B). Trophozoites (Tz) of app and pm4 
have an aberrant morphology as visible on Giemsa-stained 
smears, exhibiting an accumulation of translucent vesicles in-
side their cytoplasm (Fig. 1 C). The reduced Hz production in 
pm4 and app mutants indicate that P. berghei blood stages 
can develop into mature Sz despite significantly reduced Hb 
digestion. The lower growth rate of mutants lacking down-
stream hemoglobinases DPAP1 and LAP (but with WT Hz 
levels) indicates that these enzymes are either important in ef-
fectively releasing amino acids from Hb peptides or that they 
have additional functions. Parasites lacking APP unexpectedly 
also had reduced levels of Hz. However, both APP and LAP 
are shown to have additional roles, e.g., in cytosolic peptide 
turnover (Dalal and Klemba, 2007). Although it remains to be 
investigated, APP may have an indirect effect on the initial 
steps of Hb digestion, either resulting from its involvement in 
establishment of the DV or due to feedback mechanisms that 
inhibit Hb digestion in the absence of APP.
Parasites lacking both PM4 and BP2 are restricted to 
reticulocytes and produce smaller Szs with less merozoites
Because in P. berghei PM4 is the only DV aspartic protease and 
BP2 is the single syntenic ortholog of the two P. falciparum 
by aspartic and papain-like cysteine endoproteases, Hb unfolds 
and becomes accessible to further proteolysis by downstream 
proteases. In the P. falciparum DV, there are four aspartic prote-
ases (plasmepsins) and two papain-like cysteine proteases 
(falcipains) capable of hydrolyzing native Hb (Goldberg, 2005; 
Subramanian et al., 2009). Gene disruption studies of hemoglo-
binases demonstrated that P. falciparum has developed redundant 
and overlapping Hb degradation pathways, demonstrating the 
importance of Hb digestion for the parasite (Liu et al., 2006; 
Bonilla et al., 2007). However, Hb is a poor source of methio-
nine, cysteine, glutamine, and glutamate; in addition, human 
Hb contains no isoleucine and P. falciparum blood-stage parasite 
growth is most effective in culture medium supplemented with 
these amino acids, especially isoleucine (Liu et al., 2006). These 
data indicate that P. falciparum parasites are not only dependent 
on Hb digestion, but also import exogenous amino acids (Liu 
et al., 2006; Elliott et al., 2008).
Most studies on Hb degradation have been performed 
using P. falciparum maintained with mature RBCs (normo-
cytes) in vitro. It is unknown whether observations on P. fal-
ciparum Hb digestion made in vitro can be directly translated 
to parasites replicating in vivo or for parasites developing in 
reticulocytes such as the human parasite P. vivax and P. ovale. 
For example, mechanisms of resistance to some drugs that in-
terfere with Hb digestion and heme detoxification (e.g., chlo-
roquine) differ between P. vivax and P. falciparum (Baird, 2004; 
Baird et al., 2012) indicating that there may be differences in 
their Hb digestion pathways.
To obtain a better insight into Hb digestion in parasites 
developing in vivo we used a rodent malaria parasite, P. berghei, 
which preferentially invades reticulocytes. We show a high 
level of functional redundancy among the predicted hemo-
globinases, as 6 of the 8 are dispensable in vivo. Unexpectedly, 
we were able to create parasite mutants lacking the enzymes 
known to initiate Hb digestion. These parasites were able to 
multiply in reticulocytes without Hz formation and were re-
sistant to chloroquine.
RESULTS AND DISCUSSION
High degree of functional redundancy  
among Plasmodium hemoglobinases
To determine the essential nature of individual enzymes in-
volved in P. berghei Hb digestion, we performed a loss-of-
function analysis on eight predicted P. berghei hemoglobinases. 
The selection was based on the corresponding P. falciparum 
orthologous proteases with a characterized role in Hb diges-
tion and/or located in the digestive vacuole (DV; Table S1 and 
Fig. 1 A). These include the aspartic protease, plasmepsin 4 
(PM4), a single enzyme equivalent to the 4 P. falciparum plas-
mepsins (PM1–4); berghepain-2 (BP2), equivalent to the 2 
P. falciparum DV falcipains FP-2 and FP-3; bergheilysin (BLN), 
the ortholog of P. falciparum falcilysin; dipetidyl peptidase 1 
(DPAP1); and 4 aminopeptidases (aminopeptidase P [APP], 
M1-family alanyl aminopeptidase [AAP], M17-family leucyl 
aminopeptidase [LAP], and M18-family aspartyl aminopepti-
dase [DAP]). In addition, we included heme detoxification 
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and reticulocytes, mature Tz and Sz were exclusively found in 
reticulocytes (unpublished data), indicating that pm4bp2 para-
sites, while retaining their ability to invade all RBCs, are un-
able to develop in normocytes. This may be related to greater 
abundance/diversity of amino acids and proteins present in 
reticulocytes (Allen, 1960), or due to other physical charac-
teristics of reticulocytes, for example, their larger size and re-
duced Hb content may provide more space for growth in the 
absence of Hb digestion.
Analysis of Giemsa-stained images revealed pm4bp2-
Sz to be small, occupying only 25–65% of the RBCs, com-
pared with 60–90% of WT Sz (n > 30; Fig. 2 A). This size 
reduction was confirmed by ImageStream flow cytometry on 
DV cysteine endoproteases (FP-2 and FP-3), the absence of 
these enzymes is expected to result in the failure to proteolyse 
native Hb. Unexpectedly, we were able to generate two in-
dependent mutants lacking expression of both PM4 and BP2 
(pm4bp2; Table S2). Blood stages of pm4bp2 have a se-
verely reduced multiplication rate (2.2–4.6 compared with 
WT rates of 10; Table 1). After an initial slow rise of parasite 
numbers in pm4bp2-infected mice, parasitemia can reach 
levels of up to 50% when mice became anemic and the RBCs 
were principally reticulocytes (unpublished data). At high 
parasitemias, mature Sz were present in the blood, most of 
which contained 8–12 merozoites (Fig. 2 A). Even though 
ring forms of pm4bp2 were observed in both mature RBCs 
Figure 1. pm4 and app parasites show reduced Hz levels and an aberrant morphology. (A) Reflection contrast polarized light microscopy was 
used to quantify Hz production inside an iRBC; representative images of Hz in mature Szs are shown. Hz crystals are scattered in Szs and were used for 
Hz quantification; a single Hz cluster is only observed in fully segmented Szs (blue box); BF, bright field; bars, 5 µm. (B) Relative light intensity (RLI) of 
polarized light was measured for individual Szs (n > 30; Student’s t test; ***, P < 0.0001). (C) Aberrant morphology of pm4 and app Tzs exhibiting  
reduced Hz production and an accumulation of translucent vesicles (indicated by arrows) in their cytoplasm. Bars, 5 µm. The phenotype was confirmed 
with two independent mutants.
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These vesicles are very similar to those that have been de-
scribed in P. falciparum Tz when Hb trafficking or digestion is 
blocked by inhibitors, and it has been proposed that these 
vesicles are cytostome derived and contain concentrated un-
digested and/or denatured Hb (Fitch et al., 2003; Vaid et al., 
2010). In addition, although WT Tz contained large num-
bers of Hz crystals, >40% of pm4bp2 Tz had no visible Hz 
crystals (Fig. 3 A), reflecting our observations with Giemsa-
stained images of Tz and Sz (Fig. 2 A). Next, we used reflec-
tion contrast polarized light-microscopy to determine the 
amount of Hz in maturing pm4bp2-Sz and WT-Sz. The 
relative light intensity (RLI) values of pm4bp2-Sz at all 
stages of maturation were strongly reduced (78–87% reduc-
tion compared with WT Sz; Fig. 3 B and Table 1), and 
whereas all WT Sz had Hz, a large percentage (35–48%) of 
pm4bp2-Sz had no detectable Hz (Fig. 3 B), having RLI 
values the same as uninfected RBCs. The severe reduction in 
Hz production was also reflected in vastly reduced Hz depo-
sition in organs of pm4bp2-infected mice compared with 
WT- and even pm4-infected mice (Fig. 3 C).
We further quantified the amount of Hz and undigested 
Hb in equal numbers of FACS-purified Sz using heme- 
dependent luminol-enhanced luminescence analysis (Schwarzer 
et al., 1994). The Hb that remained undigested in pm4bp2-
Sz iRBCs was twice the amount of that in WT-Sz iRBCs 
(Fig. 3 D); however, the total heme content in pm4bp2-Sz 
live WT and pm4bp2 Szs expressing GFP under the con-
trol of the Sz-specific ama-1 promoter (Fig. 2 B). Analysis of 
Giemsa-stained parasites indicated that pm4bp2 Szs had 
fewer merozoites (Fig. 2 A). Measuring GFP and Hoechst 
fluorescence intensity by ImageStream and standard flow cy-
tometry confirmed that mature pm4bp2-Sz have 40% re-
duction in both total DNA and (ama1-based) GFP expression 
levels compared with WT Sz, indicating a significant reduc-
tion in the total number of merozoites per Sz (Fig. 2, C and D). 
Combined, these observations demonstrate that pm4bp par-
asites produce smaller Sz with less daughter merozoites than 
WT Sz.
Parasites lacking both PM4 and BP2 can form  
Szs in the absence of detectable Hz
Most pm4bp2 Tzs have an amoeboid-like appearance 
with translucent vesicles inside their cytoplasm, and their Tzs 
and Szs have little or no visible Hz (Fig. 2 A). Ultrastructural 
analyses confirmed this, showing that pm4bp2 Tzs con-
tained a higher number of cytostomes or endocytic vesicles 
filled with material that had a structural appearance similar to 
RBC cytoplasm (Fig. 3 A). This indicates that the absence of 
PM4 and BP2 does not affect the uptake of Hb from the 
RBC cytoplasm. Electron microscopic images revealed that 
37% of the Tzs contained dark-stained (electron-dense) vesi-
cles that are completely absent from WT parasites (Fig. 3 A). 
Table 1. Growth and virulence characteristics of blood stages of gene deletion mutants
Gene deletion mutant Day to 0.5–2% parasitemiaa Multiplication rateb Hz productionc
WTd 8 (0.2); n = 40 10.0 (0.7) 198.8 (69.8)
pm4-ae 9-11; n > 10 5.8 (0.5)-7.0 (1.0)f 129.5 (41.7)f
pm4-b 9 (0); n = 2 7.7 (0)f 134.5 (47.6)f
bp2-a 8 (0); n = 5 10.0 (0) 177.5 (45.1)
bp2-b 8 (0); n = 6 10.0 (0) 188.4 (71.5)
dpap1-a 9.5 (0.7); n = 2 7.0 (1.0)f 174.6 (34.0)
dpap1-b 9 (0); n = 4 7.7 (0)f 189.2 (62.7)
app-a 12 (0); n = 1 4.6 (0)f 131.8 (50.5)f
app-b 12 (0); n = 4 4.6 (0)f 111.4 (49.7)f
dap 8 (0); n = 3 10.0 (0) 223.8 (65.7)
lap 15.5 (0.7); n = 2 3.3 (0.2)f 213.6 (78.7)
bp1-a 9.7 (0.6); n = 3 6.8 (0.8)f 186.2 (49.2)
bp1-b 9 (0); n = 1 7.7 (0)f n.d.
dpap2 8.3 (0.4); n = 4 9.4 (1.0) 187.8 (64.6)
dpap3-a 8.3 (0.6); n = 3 9.2 (1.3) 184.5 (86.3)
dpap3-b 8 (0); n = 5 10.0 (0) 193.3 (46.8)
pm4bp2-a 12, 16, 20; n = 3 3.4 (1.1)f 27.2 (36.5)f
pm4bp2-b 21, 24; n = 2 2.3 (0.1)f 46.1 (51.2)f
n.d., not determined.
aThe day on which the parasitemia reaches 2—5% in mice infected with a single parasite in cloning assays. The mean of one cloning experiment and standard deviation are 
shown (n = the number of mice). For the pm4bp2 mutants, the days for individual clones are shown.
bThe multiplication rate (mean and SD) of asexual blood stages per 24 h, calculated based on the “day to 0.5–2% parasitemia” in the cloning assay.
cRelative light intensity (mean and SD) of Hz crystals in individual Szs, determined by polarized light microscopy. See Fig.1.
dWT, wild type P. berghei ANKA reference lines (cl15cy1, 676m1cl1, and 1037cl1). Data from >10 independent experiments.
epm4 gene-deletion mutants generated by Spaccapelo et al. (2010).
fP < 0.0001; Student’s t test.
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P. berghei aspartyl and cysteine endopeptidases overlap in their 
ability to hydrolyze Hb. Interestingly, the bp2 mutant has a 
normal growth rate and produces WT levels of Hz, whereas 
pm4 parasites have a reduced growth and Hz production. 
These observations demonstrate that although PM4 is able to 
fully compensate for the function of BP2, BP2 can only partly 
compensate for the loss of PM4.
Gametocytes of parasite lacking both PM4 and BP2 are 
fertile despite their smaller size and reduced Hz levels
In mice infected with pm4bp2 parasites, male and female 
gametocytes were readily detected. Similar to Sz, they were 
23% smaller than WT gametocytes, and their cytoplasm had 
strongly reduced or no Hz crystals (Fig. 4 A). Most pm4bp2 
male gametocytes produced motile gametes (79.3 ± 4.6%), 
which are able to fertilize female gametes and produce ooki-
netes; these undergo meiosis and become tetraploid (Fig. 4, 
B and C). The conversion rates of pm4bp2 female gametes 
into ookinetes were comparable to those of WT parasites 
(60.0 ± 6.1%; Fig. 4 C). Analysis of Hz levels in WT and 
pm4bp2 ookinetes revealed that they also had reduced 
iRBCs was 40% lower than WT-Sz iRBCs. On average, 54% 
(between 20–100%) of Hb remains undigested in pm4bp2-Sz 
iRBCs, compared with 12% of WT-Sz iRBCs (Fig. 3 D). 
Combined, the increased number of cytostome inclusions, 
presence of unusual electron-dense vesicles and severely re-
duced and often absent Hz crystals indicate that Hb digestion 
is severely impaired in pm4bp2 and this is further sup-
ported by the high levels of undigested Hb present in RBCs 
infected with pm4bp2 Sz compared with WT-Sz. How-
ever, some Hz is still present in a proportion of pm4bp2 
parasites indicating that some heme is released from Hb in the 
absence of PM4 and BP2. Whether this is the result of a com-
pensatory enzymatic process or a nonspecific disassembly of 
the Hb tetramer that may occur when Hb accumulates in cy-
tostomes or in the acidified dark-staining vesicles (Fitch et al., 
2003) is unknown and requires further investigation.
In P. falciparum the PMs and FPs overlap in function and 
there is extensive functional redundancy within and be-
tween these two protease classes (Bonilla et al., 2007; Liu 
et al., 2006). Our observations on Hz production in the single 
gene-deletion mutants pm4 and bp2 indicate that also in 
Figure 2. Szs of mutants lacking PM4 and BP2 expression are smaller in size and produce fewer merozoites. (A) Representative Giemsa-stained 
images showing the difference in size and merozoites production of pm4bp2 iRBCs relative to WT. Bars, 5 µm. (B) Images of Hoechst stained mature 
WT and pm4bp2 Szs expressing GFP under Sz-specific ama1 promoter in their cytoplasm (right) and their size measurement by ImageStream flow 
cytometry (left). Bars, 5 µm. The size of individual iRBC was determined from bright field images (B) and the size of Sz was measured from the combined 
GFP (G) and Hoechst (H) images (i.e., G+H). M, merged images (n > 250; ***, P < 0.0001; Student’s t test). (C) The dot plot (left) generated from Image-
Stream flow cytometry shows the GFP- and Hoechst-fluorescence of individual WT- (green) and pm4bp2- (red) Sz, and the GFP expression and DNA 
content were quantified (right). (D) The GFP and DNA content of mature Szs were measured by standard flow cytometry; mature Szs were selected in 
Gate 1 (left) and the quantification shown as bar graphs (right). All data are representative of two independent experiments (bar graphs show mean fluor-
escence intensity with SEM; ***, P < 0.0001; Student’s t test).
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Figure 3. pm4bp2 mutant parasites 
can develop into mature Szs with reduced 
Hb digestion and little or no detectable 
Hz. (A) Electron microscopy images of 
pm4bp2 and WT-Tzs were used to identify 
and calculate the number of Hz crystals (red 
arrows), cytostomes (C), and dark-staining 
vesicles (DSV, white arrows) in WT and 
pm4bp2 parasites. Data were obtained 
from 3 EM image fields (n > 60; ***, P < 
0.0005; Student’s t test). N, nucleus. Bars,  
5 µm. (B) Reflection contrast polarized light 
microscopy was used to quantify Hz produc-
tion in pm4bp2 and WT Sz. Bright field 
(BF) and polarized light microscopy images 
showing Hz in individual representative  
Sz (left). Relative light intensity (RLI) of Hz  
crystals was measured in individual WT or 
pm4bp2 Sz containing either 2–4, 5–8,  
or >8 nuclei (N; n > 20; ***, P < 0.0005; Stu-
dent’s t test; right). Bars, 5 µm. (C) Hz deposi-
tion in different organs of BALB/c mice 
infected with WT or pm4bp2-parasites at 
different days after infection was quantified. 
The deposition of Hz in different organs at 
different days (left; data presented as mean 
with SEM; n = 4) and the relationship be-
tween total Hz levels (nmol) quantified from 
all organs and peripheral parasitemias (right); 
**, P < 0.05; ***, P < 0.0005 (Student’s t test). 
(D) Quantification of total Hb and undigested 
Hb, using heme-dependent, luminol-enhanced 
luminescence, in WT and pm4bp2 Sz 
iRBCs; Hb and Hz levels in mature RBC and 
reticulocytes (left; data presented as mean 
with SEM) and the percentage of undigested 
Hb in these cells (right) are shown. *, P < 0.05; 
**, P < 0.005; ****, P < 0.001; Student’s t test, 
n > 3. Data were pooled from three indepen-
dent experiments.
Hz-levels (57%; Fig. 4 C). These observations demonstrate 
that both asexual and sexual blood-stages can complete devel-
opment despite the severely impaired Hb digestion.
Parasites lacking both PM4 and BP2 are resistant  
to chloroquine but retain their sensitivity to artesunate
We tested the sensitivity of the pm4bp2 parasites to artesu-
nate (AS) and chloroquine (CQ); their mode of action is be-
lieved to depend on Hb digestion/Hz formation (Egan et al., 
2004; Klonis et al., 2011). As a control we used sulfadiazine 
(SD), an inhibitor of folic acid synthesis (Kinnamon et al., 
1976). AS and SD treatment of WT- and pm4bp2-infected 
BALB/c mice resulted in rapid clearance of parasites from 
bloodstream in 3–4 and 4–5 d after start of AS (50 mg/kg 
body weight, i.p.) and SD (35 mg/liter in drinking water) 
treatment, respectively (Fig. 5 A). Similarly, BALB/c mice 
infected with WT parasites rapidly cleared their infection 
after CQ (288 mg/liter in drinking water) treatment (3–4 d). 
In contrast, mice infected with pm4bp2 parasites, first exhib-
ited an increase in parasitemia for 3 d, followed by a slow de-
cline (Fig. 5 A). Parasites with normal morphology were 
present 6 d after start of CQ treatment (Fig. 5 B). Untreated 
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restricted to development in reticulocytes and produced less Hz 
(Platel et al., 1999). It has been proposed that CQ-resistance 
of parasites with reduced Hz is due to detoxification of hemin 
by elevated levels of glutathione in parasites inside reticulo-
cytes, thus precluding heme-polymerization and preventing 
CQ activity (Platel et al., 1999; Fidock and DeSilva, 2012). 
However, our observations may provide a more direct expla-
nation for CQ-resistance and reduced Hz production in these 
parasites, namely that these parasites, like the pm4bp2, di-
gest less Hb in reticulocytes.
Our observations may have particular relevance for the 
human malaria parasite, Plasmodium vivax, which is also retic-
ulocyte-restricted. P. vivax CQ resistance appears to be dif-
ferent from P. falciparum (Suwanarusk et al., 2007; Baird et al., 
2012), and no clear association has been found with muta-
tions in the same genes that typify P. falciparum CQ resistance 
(pfcrt or pfmdr1). In addition, DV formation in P. vivax ap-
pears to resemble more DV formation in P. berghei than in 
P. falciparum. Tzs of P. falciparum have a large central DV, as Hb-
containing cytostomes merge rapidly and Hz formation occurs 
principally in this single DV. In contrast, P. berghei has many 
small Hb-containing vesicles, in which Hb digestion/Hz for-
mation occurs, resulting in scattered Hz granules throughout 
BALB/c mice also resolved a pm4bp2 infection 3–4 wk 
after infection, indicating that host immunity may contribute 
to the decline of parasitemia in CQ-treated mice. We therefore 
performed infections and CQ treatment in Rag2/c/ 
mice (deficient in B, T, and NK cells). Whereas CQ-treated, 
WT-infected mice cleared a 2–5% WT infection within 3 d, 
in pm4bp2-infected mice parasites persisted for >20 d of 
CQ-treatment (Fig. 5 C), during which only Hz-negative 
pm4bp2 parasites were observed in circulation (Fig. 5 D). 
To examine whether pm4bp2 parasite resistance to CQ is 
lost at higher concentrations of CQ and conversely if resistance 
to AS is observed at lower concentrations of AS, we performed 
drug sensitivity assays using 5 and 10 mg/kg AS (in BALB/c 
mice) or with 600 mg/liter CQ (in Rag2/c/ mice). 
These experiments revealed that, at lower AS doses, drug sen-
sitivity does not significantly differ between pm4bp2 and 
WT parasites, and that pm4bp2 parasites are resistant to 
CQ even at high doses (Fig. 5 E).
Our observations on the ability of Plasmodium parasites to 
develop without detectable Hz formation that are resistant to 
CQ indicate a novel mechanism of resistance against drugs 
that target Hb proteolysis. Interestingly, previous studies on 
CQ-resistant P. berghei lines revealed that parasites are more 
Figure 4. Gametocytes of pm4bp2 
are fertile despite their smaller size and 
reduced Hz production. (A) Representative 
Giemsa-stained images of WT and pm4bp2 
gametocytes (left; bars, 5 µm) and the size 
quantification on these images (right; n > 30; 
***, P < 0.0001; Student’s t test). (B) Giemsa-
stained images and polarized light microscopy 
images of ookinetes. BF, bright-field; Nuclei 
(blue) stained with Hoechst. Bars, 5 µm.  
(C) Hoechst fluorescence intensity (DNA  
content) of WT and pm4bp2 ookinetes, 
relative to haploid ring-form stages, was 
quantified (left; n > 25; n.s, not significant; 
Student’s t test) indicating that both WT and 
pm4bp2 ookinetes are tetraploid. Relative 
light intensity (RLI) of polarized light  
(Hz production) measurements of WT and 
pm4bp2 ookinetes (right; n > 25;  
***, P < 0.0001; Student’s t test).
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Moreover P. vivax, like P. berghei, has only 1 DV plasmepsin 
(PM4) in contrast to P. falciparum which encodes 4 DV plas-
mepsins (Table S1). While P. vivax has 3 DV vivapains, 2 of 
them, VX2 and 3, are syntenic orthologs of FP-2 and 3 the 
other, VX4, is nonsyntenic with the FPs but shows greater 
the cytoplasm of the parasite, these clusters coalesce when 
schizogony starts (Slomianny et al., 1985). It has been suggested 
that the uptake of Hb from reticulocytes by the process of 
micropinocytosis results in multiple small vesicles containing 
Hb and Hz in both P. berghei and P. vivax (Jeffers, 2010). 
Figure 5. pm4bp2 parasites are resistant to chloroquine but sensitive to artesunate. (A) Changes in parasitemia of BALB/c mice (n = 5) in-
fected with WT or pm4bp2 parasites after treatment with chloroquine (CQ; 288mg/liter in drinking water; 2 experiments), artesunate (AS; 50 mg/kg 
body weight i.p), or sulfadiazine (SD; 35 mg/liter in drinking water). Data presented as mean with SEM. (B) Representative Giemsa-stained images of 
pm4bp2-Tzs in blood of BALB/c mice treated with CQ treatment at different days (D1, 3, 6) after start of CQ treatment. Bars, 5 µm. (C) Changes in para-
sitemia of Rag2/c/ (n = 6) mice infected with WT or pm4bp2 parasites either without treatment (left) or after prolonged CQ treatment (right; 
288 mg/l in drinking water; 2 experiments). (D) Reflection contrast polarized light microscopy images (RCM) showing the absence of Hz crystals in 
pm4bp2 parasites that survived CQ treatment for >20 d in Rag2/c/ mice; iRBC with no Hz formation are indicated by red arrows. In untreated 
mice, two populations of pm4bp2 parasites are present, parasites with no Hz (red arrow), and parasites with Hz crystals (yellow arrows). WT parasites 
in untreated mice show large amounts of Hz (yellow arrows). Black arrows indicate iRBC in bright field (BF) images. Nuclei of parasites (blue) were stained 
with Hoechst (blue arrows). Bars, 5 µm. (E) Changes in parasitemia of BALB/c mice (top, n = 5) or Rag2/c/ mice (bottom, n = 5) infected with 
pm4bp2 and WT parasites exposed to either 5 or 10 mg/kg of AS in or to 600 mg/l CQ in drinking water. Data presented as mean values of changes 
(%) in parasitemia with SEM.
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sequence similarity to BP2 (Na et al., 2010; Table S1). These 
observations indicate that mechanisms of Hb uptake and 
digestion in P. vivax more closely resembles P. berghei than 
P. falciparum and future research is required to see if this also 
translates into similar mechanisms to resistance to drugs that 
exclusively target Hb digestion pathways.
Although pm4bp2 parasites are resistance to CQ, they 
retain sensitivity to AS. Although the precise mode of action 
of artemisinin and related derivatives remains contentious, it 
is believed that their activity results from activation by re-
duced heme iron in the DV (Eastman and Fidock, 2009). Our 
results suggest AS activity is not affected by reduced Hb di-
gestion or absence of Hz formation. Alternatively AS activa-
tion in pm4bp2 parasites in reticulocytes may derive from 
a labile pool of heme that exists in reticulocytes for Hb syn-
thesis. P. vivax resistance to artemisinins has not been reported; 
however, most of the artemisinin-based combination therapies 
have proven efficacy against chloroquine-resistant strains of 
P. vivax (Price et al., 2014).
We show that, very much counter to expectation, Hb di-
gestion and Hz formation appears not to be essential to para-
site survival when parasites develop in reticulocytes. Indeed, 
our findings support the notion that Plasmodium parasites re-
tain multiple modes of development and survival during blood 
stage development, which has important implications for an-
timalarial drug design, in particular drugs that target Hb di-
gestion and Hz formation.
MATERIALS AND METHODS
Experimental animals and parasites. Female C57BL/6, BALB/c, Swiss 
OF1 mice (6–8 wk old; Charles River) and female Rag2/c/ mice (6–8 wk 
old, bred in MRC NIMR) were used. All animal experiments performed at the 
Leiden University Medical Center (LUMC) were approved by the Animal Ex-
periments Committee of the LUMC (DEC 10099; 12042; 12120). All animal 
experiments performed at the University of Perugia were approved by Minis-
try of Health under the guidelines D.L. 116/92). All animal experiments per-
formed in MRC NIMR were performed after review and approval by the 
MRC National Institute for Medical Research Ethical Review Panel in strict 
accordance to current UK Home Office regulations, and conducted under the 
authority of UK Home Office Project License PPL 80/2358. The Dutch, Ital-
ian, and British Experiments on Animal Act were established under European 
guidelines (EU directive no. 86/609/EEC regarding the Protection of Animals 
used for Experimental and Other Scientific Purposes).
Two reference P. berghei ANKA parasite lines were used: line cl15cy1 (WT) 
and reporter line 1037cl1 (WT-GFP-Lucschiz; mutant RMgm-32). This reporter 
line contains the fusion gene gfp-luc gene under control of the Sz-specific ama1 
promoter integrated into the silent 230p gene locus (PBANKA_030600) and 
does not contain a drug-selectable marker (Spaccapelo et al., 2010).
Generation of P. berghei mutants. DNA constructs used to disrupt genes 
were based on the standard plasmids (pL0001 [MRA-770], pLTgDFHR, 
and pL0035; [MRA-850]) and by modified PCR methods based on pL0040 
and pL0048 (Lin et al., 2011). Targeting sequences for homologous recom-
bination were PCR amplified from P. berghei ANKA (cl15cy1) genomic 
DNA using primers specific for the 5 or 3 end of each gene using primer 
sets of P1/P2, P3/P4, respectively (see Table S3 for the primer sequences).
The DNA construct targeting bp1 was provided by P. Sinnis (Johns 
Hopkins University, Baltimore, MD). Transfection, selection, cloning, and 
genotyping of transformed parasites was performed using standard genetic 
modification technologies for P. berghei (Janse et al., 2006). To generate 
pm4bp2 mutant, hdhfr::yfcu selectable marker was removed by negative 
selection (Braks et al., 2006) from bp2-b (based on pL0035) and pm4 gene 
was subsequently targeted in bp2-b-sm line. Table S2 provides details of all 
gene deletion experiments, such as experiment number, targeting construct, 
parental line for transfection, and RMgmDB IDs (Rodent Malaria Geneti-
cally Modified Parasites Database). Details for targeting construct generation 
(maps and sequences) and genotyping results can be found in RMgmDB and 
Table S4 includes primers used for genotyping including diagnostic PCR, 
Southern analyses of chromosomes separated by pulsed-field gel electropho-
resis, Northern PCR, and RT-PCR.
In vivo asexual multiplication (growth) rates. The multiplication 
(growth) rate of asexual blood-stages in mice was determined during cloning 
of the gene-deletion mutants as described before (Spaccapelo et al., 2010) 
and was calculated as follows: the percentage of infected erythrocytes (para-
sitemia) in Swiss OF1 mice injected with a single parasite was determined by 
counting Giemsa-stained blood films when parasitemias reach 0.5–2%. The 
mean asexual multiplication rate per 24 h was then calculated assuming a 
total of 1.2 × 1010 erythrocytes per mouse (2 ml of blood). The percentage 
of infected erythrocytes in mice infected with reference lines of the P. berghei 
ANKA strain consistently ranged between 0.5–2% at day 8 after infection, 
resulting in a mean multiplication rate of 10 per 24 h.
Gametocyte and ookinete production. Gametocyte production is de-
fined as the percentage of ring forms developing into mature gametocytes 
during synchronized infections (Janse and Waters, 1995). Male gamete pro-
duction (exflagellation) and ookinete production was determined in standard 
in vitro fertilization and ookinete maturation assays (Janse and Waters, 1995); 
ookinete production is defined as the percentage of female gametes that de-
velop into mature ookinetes under standardized in vitro culture conditions. 
Female gamete and mature ookinete numbers were determined on Giemsa-
stained blood smears made 16–18 h after activation. Hz level of ookinetes 
were quantified.
Sz and gametocyte size measurements. For the Giemsa-stained smears, 
pictures were taken using a Leica microscope from randomly chosen fields 
of 300–400 RBCs, and all iRBCs were measured in these fields. The sizes of 
iRBCs and the parasites were measured by ImageJ by gating on the areas of 
parasites and iRBC. For ImageStream flow cytometry analysis, iRBCs con-
taining Szs of WT-GFP-Lucschiz and pm4bp2 parasites were collected from 
infected BALB/c mice with a high parasitemia (10–30%) and enriched by 
Nycodenz density centrifugation (Janse et al., 2006). Purified parasites were 
then collected in complete RPMI-1640 culture medium and stained with 
Hoechst-33258 (2 µmol/liter; Sigma-Aldrich) for 1 h at room temperature. 
Cultured, mature Szs of WT P. berghei ANKA (cl15cy1) were used as un-
stained control; Hoechst stained cl15cy1 (Hoechst only) and nonstained 
WT-GFP-Lucschiz (GFP only) were used as single-color controls. The analyses 
were performed using an Amnis ImageStream X imaging cytometer (Amnis 
Corp.) and images were analyzed using the IDEAS image analysis software.
Hz and Hb quantification. Hz was quantified in Szs using different meth-
ods. Hz was quantified by measuring the relative light intensity (RLI) of Hz 
crystals in Szs and ookinetes by reflection contrast polarized light micros-
copy. Szs were either collected from overnight in vitro blood stage cultures 
or directly from tail blood when Szs were present in the peripheral circula-
tion. Blood smears were made from cultured parasites or from tail blood and 
stained with Hoechst-33342 (2 µmol/liter; Sigma-Aldrich) for 20 min. Szs 
(8–24 nuclei) with scattered Hz were selected and pictures were taken with 
a LeicaDM/RB microscope (Leica) which was adapted for reflection con-
trast polarized light microscopy (Cornelese-ten Velde et al., 1988). The RLI 
of Hz crystals in the Szs was measured using ImageJ software (NIH).
In addition, Hb and Hz from WT and pm4bp2 Sz-iRBC were quan-
tified by measuring the heme-dependent luminol-enhanced luminescence 
(Schwarzer et al., 1994). For these experiments, 104 purified Szs were collected 
by flow sorting from infected blood of BALB/c mice with a high parasitemia 
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Table S1. P.berghei Genes targeted in this study 
Product name 
P. falciparum Gene ID 
Localization  
(Pf) 
Essential for 
blood stages 
(Pf) 
Product name 
P. berghei Gene ID 
Essential for 
blood stages 
(Pb) * 
Product name 
P. vivax Gene ID 
aspartic endoprotease     
plasmepsin I (PM I) 
PF3D7_1407900 
DV no   -  -  
plasmepsin II (PM II) 
PF3D7_1408000 
DV no   -  -  
plasmepsin IV (PM IV) 
PF3D7_1407800 
DV no  plasmepsin 4 (PM4) 
PBANKA_103440 
no  plasmepsin 4 (PM4) 
PVX_086040 
plasmepsin III (PM III) 
PF3D7_1408100 
DV no   -  -  
papain-like cysteine  endoprotease     
falcipain 2a (FP 2a) 
PF3D7_1115700 
DV no  berghepain-2 (BP2) 
PBANKA_093240 
no *  vivapain-2(VX2) 
PVX_091415 
falcipain 2b (FP 2b) 
PF3D7_1115300 
DV no   -  -  
falcipain 3 (FP 3) 
PF3D7_1115400 
DV  yes   -  - vivapain-3 (VX3) 
PVX_091410 
     vivapain-4 (VX4) 
PVX_091405 
metallopeptidase      
falcilysin (FLN)  
PF3D7_1360800 
DV, mitochondrion, 
apicoplast 
yes bergheilysin (BLN) 
PBANKA_113700 
yes * PVX_115000 
dipeptidyl aminopeptidase     
dipeptidyl aminopeptidase 1 
(DPAP1)  
PF3D7_1116700 
DV yes dipeptidyl 
aminopeptidase 1 
(DPAP1) 
PBANKA_093130 
no  * PVX_091465 
 
aminopeptidases      
aminopeptidase P  (APP) 
PF3D7_1454400 
DV, cytosol yes aminopeptidase P  
(APP) 
PBANKA_131810 
no  * PVX_117760 
M1- family alanyl 
aminopeptidase (M1AAP)  
PF3D7_1311800 
DV, nucleus yes M1- family alanyl 
aminopeptidase (AAP) 
PBANKA_141030 
yes  * PVX_122425 
M17-family leucyl 
aminopeptidase  (M17LAP)  
PF3D7_1446200 
DV, cytosol yes M17-family leucyl 
aminopeptidase  (LAP) 
PBANKA_130990 
no  * PVX_118180 
M18-family aspartyl 
aminopeptidase (M18DAP)  
PF3D7_0932300 
cytosol no M18-family aspartyl 
aminopeptidase (DAP) 
PBANKA_083310 
no  * PVX_087090 
heme detoxification protein     
heme detoxification protein 
(HDP)  
PF3D7_1446800 
DV yes heme detoxification 
protein (HDP) 
PBANKA_131060 
yes  * PVX_118155 
papain-like cysteine  proteases     
falcipain 1  (FP 1)  
PF3D7_1458000 
Apical end of 
merozoites 
no berghepain 1 (BP1) 
PBANKA_132170 
no  * PVX_117565 
dipeptidyl aminopeptidases     
dipeptidyl aminopeptidase 2 
(DPAP2)  
PF3D7_1247800 
 -  - dipeptidyl 
aminopeptidase 2 
(DPAP2) 
PBANKA_146070 
no  * PVX_101280 
dipeptidyl aminopeptidase 3 
(DPAP3)  
PF3D7_0404700 
 - yes dipeptidyl 
aminopeptidase 3 
(DPAP3) 
PBANKA_100240 
no *  PVX_001005 
 
 
*, the phenotype observed in this study. 
-, no published data. 
 
